Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Focus Guyana.
Press releases published on September 19, 2025
DeAgentAI (AIA) Achieves $457M Valuation Following Binance Alpha and Futures Listing
SEOUL, South Korea, Sept. 19, 2025 (GLOBE NEWSWIRE) -- DeAgentAI, the decentralized AI agent infrastructure project, has reached a fully diluted valuation of $457 million after the successful debut of its native token, AIA, on Binance Alpha and Binance …
CreateFun Showcases AI-Powered Creative Platform as Gold Sponsor at WOW Summit Hong Kong 2025
Hong Kong, China, Sept. 19, 2025 (GLOBE NEWSWIRE) -- CreateFun, the pioneering AI-powered creation platform redefining digital creativity and play, proudly participated as a Gold Sponsor at WOW Summit Hong Kong 2025, one of Asia’s most influential …
Trust Stamp announces $12.7m+ contract extension
Atlanta, GA, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Trust Stamp (Nasdaq: IDAI) has announced an amendment to the Software and Licensing Agreements with its Fortune 500 financial services customer extending the contract first entered into in November 2016 to …
SEALSQ to launch Quantum Shield QS7001 mid-November, pioneering Post-Quantum Cryptography for Cryptocurrencies and Beyond
Geneva, Switzerland, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Geneva, Switzerland, September 19, 2025 -- SEALSQ Corp (NASDAQ: LAES) ("SEALSQ" or "Company"), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology …
CrazyBulk 2025 | D-BAL, Testo-max , Trenorol , Ultimate Stack Legal Steroids Alternatives launch BY CrazyBulk In USA.
new york, Sept. 19, 2025 (GLOBE NEWSWIRE) -- NEW YORK, Sep 19, 2025 The Crazy Bulk launch effective Ultimate stack like D-Bal, Testo-Max, Trenorol line of products are designed as a legal and safer alternative to anabolic steroids. Before you read this …
Jumpstart Agent to Exhibit at Dreamforce 2025
SAN FRANCISCO, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Jumpstart Agent, a Salesforce Partner and the AI-powered platform that gets small and midsize businesses live in under a week, announced it will attend Dreamforce 2025 in San Francisco. This year, Jumpstart …
Advanced Biomed Inc. Announces Launch of A+PerfusC™ – Integrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug Discovery
[Tainan City], Taiwan, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Advanced Biomed Inc. (Nasdaq: ADVB) (the “Company”, “Advanced Biomed”), a biotechnology company focused on developing and commercializing innovative biomedical products for precision medicine and …
Clearmind Medicine Secures $10 million Securities Purchase Agreement to Explore Strategic Opportunities
Vancouver, Canada, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to …
Polyrizon Submits Pre-Sub Package to the FDA for PL-14 Allergy Blocker
Ra’anana, Israel, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a biotechnology company focusing on the development of intranasal products, today announced the submission of its full pre-submission (Pre- …
Smart Trading Ecosystem Leading the Industry - Soup Capital Exchange Officially Launches
Denver, CO, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Soup Capital LTD has officially announced the launch of its new digital asset trading platform, Soup Capital Exchange. Positioned as a "smart trading ecosystem leading the industry," the platform is set to …
NTA Implant: Solidifying Global Leadership with MDR Certification and Launching a New Era in Implantology
EGOLZWIL, Switzerland, Sept. 19, 2025 (GLOBE NEWSWIRE) -- NTA Implant, a leading brand of the Switzerland-based Pilatus Swiss Dental GmbH, has announced a strategic milestone in its global growth journey by successfully completing the rigorous MDR (Medical …
IMUNON to Present New Translational Data of IMNN-001 Supporting Phase 3 Trial of Immunotherapy for Ovarian Cancer at AACR Special Conference in Cancer Research
OVATION 3 pivotal Phase 3 trial is currently advancing IMNN-001, with several patients being treated LAWRENCEVILLE, N.J., Sept. 19, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development with its DNA-mediated …
neffy® (epinephrine nasal spray) Approved in Japan as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis)
neffy 1 mg and 2 mg doses approved by Japanese regulators neffy offers a new delivery method for epinephrine in Japan for adults and children (>15 kg) living with severe allergic reactions Alfresa Holdings, which owns the rights to market neffy in Japan, …
Nuvini Group CEO Pierre Schurmann to Participate in Keynote Presentation at Brazil Investment Week in London on September 30, 2025
NEW YORK, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Nuvini Group Limited (Nasdaq: NVNI) (“Nuvini” or the “Company”), a leading technology conglomerate in the Latin American SaaS sector, today announced that Chief Executive Officer Pierre Schurmann will …
Platinum Analytics Cayman Limited Announces Pricing of Its Initial Public Offering
Singapore, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Platinum Analytics Cayman Limited (the “Company” or “PLTS”), a software developer specializing in the provision of FX trading software development solutions, data analytics solutions and technology development …
Spectral AI Named to TIME’s List of World’s Top HealthTech Companies 2025
DALLAS, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today …
GBT Technologies Announced Non- Binding Offer to Acquire Two Hands Corporation; Builds on Merchant Banking Strategy as Wertheim & Company
WEST HOLLYWOOD, Calif., Sept. 19, 2025 (GLOBE NEWSWIRE) -- GBT Technologies Inc. (OTC Pink: (GTCH) (“GBT or the “Company”) today announced that its Board of Directors has authorized a non-binding indication of interest to acquire all of the issued and …
Vaxart Announces Withdrawal of Reverse Stock Split Proposal
SOUTH SAN FRANCISCO, Calif., Sept. 19, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT) (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform, …
Verrica Pharmaceuticals Announces That Development Partner, Torii Pharmaceutical, Receives Approval for YCANTH® (TO-208) in Japan for the Treatment of Molluscum Contagiosum
– Approval triggers $10 million cash milestone payment to Verrica – – YCANTH® approval in Japan addresses significant unmet need of patients with molluscum – – Verrica maintains ownership of global rights to YCANTH for all indications in all territories …